Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Assets: 2020-2022

Historic Current Assets for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $285.2 million.

  • Terns Pharmaceuticals' Current Assets rose 41.94% to $270.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $270.5 million, marking a year-over-year increase of 41.94%. This contributed to the annual value of $285.2 million for FY2022, which is 70.84% up from last year.
  • As of FY2022, Terns Pharmaceuticals' Current Assets stood at $285.2 million, which was up 70.84% from $166.9 million recorded in FY2021.
  • Terns Pharmaceuticals' Current Assets' 5-year high stood at $285.2 million during FY2022, with a 5-year trough of $90.9 million in FY2020.
  • Its 3-year average for Current Assets is $181.0 million, with a median of $166.9 million in 2021.
  • Data for Terns Pharmaceuticals' Current Assets shows a peak YoY soared of 83.70% (in 2021) over the last 5 years.
  • Terns Pharmaceuticals' Current Assets (Yearly) stood at $90.9 million in 2020, then skyrocketed by 83.70% to $166.9 million in 2021, then soared by 70.84% to $285.2 million in 2022.